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pines and the Caribbean Islands (Morton, 
1991; Anwar and Bhanger, 2003; Anwar et 
al., 2005). M. oleifera is a rapidly growing and 
draught resistant slender tree of approxi-
mately 10m high, which does not tolerate 
cold weather conditions (Anwar et al., 2007). 
The leaves are very palatable and a rich 
source of vitamins A, B6 and C, magnesium, 
calcium, potassium and proteins (Gopalan et 
al., 1989; Anwar et al., 2007; Peter, 2008; Rol-
ABSTRACT 
This study investigated the effect of Moringa oleifera in diabetic Wistar rats. The effect of methanol 
extract of M. oleifera at doses of 200, 400 and 800mg/kg body weight was compared to non-diabetic 
rats, diabetic control rats and diabetic rats treated with rosiglitazone (2mg/kg b.w.). Glucose levels 
were monitored within 24 hours and on day 15 of treatment. Blood samples were collected on day 16 
of treatment to determine serum lipid profile, proteins and its fractions, non-protein metabolites and 
liver enzymes. On day 15 of treatment, glucose levels of diabetic control rats decreased by 13.33%, 
rats treated with the doses of the extract decreased by 52.37%, 53.62% and 53.93%, and rats treated 
with rosiglitazone, 58.8%. Weight gain was consistent in all groups of rats except in diabetic control 
with significant weight loss (-37.12g). The lipid profile showed rats treated with the extract had higher 
triglyceride levels, but significantly (p<0.05) lower total cholesterols with lower levels of LDL-C and 
VLDL-C, and higher HDL-C. Total proteins were increased with significant (p<0.05) increases in the 
albumin fraction. Liver enzymes, urea and creatinine levels were also reduced in the extract treated 
rats. In conclusion, the extract of the leaves of Moringa oleifera reduced blood glucose levels, correct-
ed dyslipidemias of the diabetic rats, and protected the liver from alloxan-induced injury. 
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INTRODUCTION 
Moringa oleifera, the only genus in the plant 
family Moringaceae, is a plant grown in sev-
eral tropical and sub-tropical parts of the 
world for its nutritional and medicinal value 
in both humans and animals (Fahey, 2005; 
Anwar et al., 2007). It was originally a native 
of sub-Himalayan regions of North-West 
India, but now indigenous to several coun-
tries in Africa, Asia, South America, Philip-
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off et al., 2009). The flowers and young seed 
pods are also edible, while cooking oil called 
ben oil can be pressed from mature seeds 
and the seeds can also be eaten roasted 
(Schneider, 2001).  
 
The seeds of M. oleifera are traditionally used 
in several developing countries such as Su-
dan and Malavi for purification and soften-
ing of water. This has been scientifically 
proven by many workers (Kalogo et al., 
2000; Broin et al., 2002; Sharma et al., 2006). 
In the Philippines, it is used as a galacto-
gogue (Siddhuraju and Becker, 2003; Anwar 
et al., 2007). All parts of the plant; the 
leaves, flowers, seeds and oil, bark, sap and 
roots, have folkloric uses in traditional med-
icine of several countries in Asia, Africa and 
South America. The antibacterial, antiviral 
and anti-hypertensive activity of this plant 
has been scientifically proven (Faizi et al., 
1998; Dangi et al., 2003; Nikkon et al., 2003; 
Ndong et al., 2007; Peixoto et al., 2011). Sev-
eral researchers have also reported the anti-
inflammatory, antioxidant and anti-cancer 
activity of M. oleifera (Murakami et al., 1998; 
Lalas and Tsaknis, 2002; Bharali et al., 2003; 
Siddhuraju and Becker, 2003; Mahajan et al., 
2007). 
 
However, there is dearth of information on 
the effect of this plant on diabetes and its 
management, one of its traditional indica-
tions. Also, the biochemical changes that 
may accompany the consumption of M. 
oleifera extract for protracted period of up to 
15 days is yet to be reported. Related infor-
mation is limited to its hypocholesterolemic 
effect in high-fat diet fed rats and hypercho-
lesterolemic rabbits (Ghasi et al., 2000; Me-
hta et al., 2003). This experiment was aimed 
at studying the effect of Moringa oleifera in 
diabetic rats and the serum biochemical 
changes that accompanied management of 
diabetes with Moringa oleifera extract. 
 
MATERIALS AND METHODS 
Fresh leaves of Moringa oleifera were harvest-
ed from the Federal University of Agricul-
ture, Abeokuta farm. The plants were au-
thenticated by an expert at the Department 
of Forestry and Wildlife, Federal University 
of Agriculture, Abeokuta. The leaves were 
air dried at room temperature and pulverized 
after drying. Cold extraction using methanol 
as solvent was carried out. The extract was 
filtered by draining the filtrate through cot-
ton wool and filter paper. The filtrate was 
clarified by filtration through celite on water 
pump and were then concentrated in vacuo 




Forty eight adult male Wistar rats weighing 
between 150g and 250g were obtained from 
the Experimental Animal Unit of University 
of Agriculture, Abeokuta and managed un-
der standard environmental conditions of 12 
hr light: dark. They were fed with pelletized 
rat ration and allowed access to water ad libi-
tum. The rats used in this study were con-
firmed to be normoglycaemic before they 
were included in the study. The rats were 
randomly and equally divided into six groups 
of 8 rats each.  
 
Experimental  protocol 
Rats in group I served as the normal control 
rats and diabetes was not induced in these 
rats. Rats in groups II – VI were fasted over-
night and diabetes was induced after this pe-
riod by intraperitoneal injection of alloxan 
monohydrate at a dose of 100mg/kg body 
weight. Fasting blood glucose level was esti-
mated at the time of induction of diabetes 
and 2 hours post prandial with the use a 
touch glucometer (Lifescan, Johnson and 
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Johnson California). Glucose levels were 
monitored 24hrly to ensure the hyperglyce-
mic state of glucose levels of ≥190mg/dl 
was attained (data not shown). Rats with 
glucose levels lower than 190mg/dl 6 days 
post-injection of alloxan monohydrate were 
excluded from the study at this point. 
Administration of physiological saline, M. 
oleifera extract or rosiglitazone was com-
menced on the 7th day post-injection of 
alloxan, and this was noted as day 1 of treat-
ment. Rats in group II were administered 
orally with 0.9% physiological saline 
(10mg/kg), the vehicle used and these 
served as diabetic control rats for the study. 
Rats in groups III, IV and V were adminis-
tered orally with the leaf extract of Moringa 
oleifera at doses of 200mg, 400mg and 
800mg/kg body weight respectively. Group 
VI rats were administered orally with a 
standard antidiabetic drug, Rosiglitazone 
maleate® (Glaxo Welcome, S.A., Aranda de 
Duero, Spain) at a dose of 2mg/kg b.w. 
Treatment with physiological saline, extract 
or standard drug was continued for 15 days 
consecutively. On day 1 of treatment, blood 
glucose levels were monitored every 6hours 
(0 hour, 6hours, 12 hours, 18 hours and 
24hours) and also on day 15 of treatment. 
 
Blood collection and analysis 
On day 16, the rats were first weighed and 
then anesthetized with ether. About 3ml of 
blood was collected from the retro-orbital 
sinus vein into lithium heparinized bottles. 
This was centrifuged at 2,000rpm for 
10minutes and serum was harvested for bi-
ochemical analysis. Serum biochemical pa-
rameters assayed included lipid profile [total 
cholesterol (TC), high density lipoprotein 
cholesterol (HDL–C), low density lipopro-
tein cholesterol (LDL-C), very low density 
lipoprotein cholesterol (VLDL-C) and tri-
glycerides (TG) levels], total protein and its 
constituent fractions; albumin and globulin, 
non-protein metabolites (urea and creati-
nine), serum enzymes (alanine aminotrans-
ferase (ALT), aspartate aminotransferase 
(AST) and alkaline phosphatase (ALP).  
 
RESULTS 
Glucose levels and weight of rats 
Blood glucose levels decreased in rats admin-
istered with the methanol leaf extract of 
Moringa oleifera with significant (p<0.05) de-
creases observed from 18 hours post admin-
istration of graded doses of the extract 
(184.05±2.30, 188.25±3.46 and 178.27±4.34 
mg/dl) compared with their 0 hr observa-
tions. Significant (p<0.05) reduction in the 
glucose levels was also observed in rats ad-
ministered with rosiglitazone at the 18 hour 
observation (195.34±2.25 mg/dl). On the 
other hand, diabetic rats administered with 
the vehicle only recorded a steady increase in 
their blood glucose levels through the 24 
hour post-treatment observation 
(209.20±3.79 mg/dl) (Table 1).  
 
The blood glucose levels of the rats treated 
with the extract and rosiglitazone had re-
turned to normal levels by day 15, but the 
diabetic untreated rats had maintained high 
blood glucose levels (169.12±2.25 mg/dl). A 
significant reduction in the blood glucose 
levels was observed between the 0 hr and 
day 15 observations with 52.37%, 53.62% 
and 53.93% decrease in blood glucose of rats 
treated with the extract, 58.80% decrease in 
rats treated with rosiglitazone, but 13.33% 
decreased in untreated rats.  
 
A steady weight gain was observed in the 
normal control rats (8.51±1.14 g) and rats 
administered with the extract dose at 200 
and 400mg/kg (7.97±0.76 and 8.49±0.25 g). 
A significant (p<0.05) increase in the weight 
gain was observed for rats administered with 
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800mg/kg dose of the extract (10.95±0.19 
g) and rosiglitazone (13.94±0.97 g) com-
pared with the normal control rats. Howev-
er, the diabetic control rats lost weight (-
37.12±2.19 g) when their weight on day 15 
(137.88±5.42 g) was compared to their 




The lipid profile showed that serum triglyc-
eride levels in all the diabetic rats increased 
except in rats administered with the extract 
at a dose of 800 mg/kg. Significant increas-
es were observed in diabetic control rats 
treated with the vehicle only (120.14±4.23 
mg/dl) and those administered with rosig-
litazone (102.13±4.63 mg/dl). Total choles-
terol and low density lipoprotein levels were 
significantly (p<0.05) reduced in rats treated 
with the graded doses of the extract, and 
high density lipoprotein levels increased in 
these rats, particularly in rats administered 
with 400 mg/kg dose of the extract 
(54.88±4.70 mg/dl) compared to the con-
trol group rats (Table 3). 
 
Serum Proteins, enzymes and non-
protein metabolites 
Serum  protein   levels   increased   in   rats  
administered with the extracts at dose of 200 
mg/kg (6.11±0.57 mg/dl) 400 mg/kg 
(6.00±0.34 mg/dl) and 800 mg/kg 
(5.67±0.37 mg/dl), but reduced in rats treat-
ed with rosiglitazone (5.53±0.36 mg/dl) and 
diabetic control rats (4.33±0.36 mg/dl) com-
pared with normal control rats (5.60±0.24 
mg/dl). Albumen fraction of the protein in-
creased, while globulin fraction reduced in 
rats administered with the extract. All the 
liver enzymes increased in diabetic untreated 
rats, but ALP and AST levels reduced in rats 
administered with the extracts or rosiglita-
zone, while ALT levels were slightly elevat-
ed. Blood urea and creatinine levels also re-
duced in rats treated with the extract at doses 
of 200 mg/kg (8.25±0.98 mg/dl and 
0.17±0.02 mg/dl), 400 mg/kg (8.00±0.71 
mg/dl and 0.14±0.02 mg/dl), and 800 mg/
kg (8.50±0.72 mg/dl and 0.14±0.01 mg/dl), 
and rosiglitazone treated rats (8.13±0.83 
mg/dl and 0.13±0.03), but were elevated in 
the diabetic control rats (14.00±1.20 mg/dl 
and 0.31±0.04 mg/dl) compared to the nor-
mal control rats (8.88±0.90 mg/dl and 
0.24±0.03 mg/dl) (Table 4). 
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Table 1: Effect of Moringa oleifera leaf extract on blood glucose levels (mg/dl) of                  
             diabetic rats at 0 hr, 6 hr, 12 hr, 18 hr, 24 hr and day 15 post administration of extract 












0 hr 95.62±2.13 195.05±4.69 197.61±2.49 200.5±4.12 202.7±3.90 210.28±3.17 
6 hr 98.78±2.78 195.99±4.19 194.33±3.12 199.4±6.89 195.91±5.12 208.00±4.76 
12 hr 96.98±1.90 200.40±4.42 191.46±5.10 194.4±3.98 186.98±4.13* 202.73±3.15 
18 hr 93.67±2.16 206.30±2.39 184.05±2.30* 188.25±3.46* 178.27±4.34* 195.34±2.25 
24 hr 94.58±2.32 209.20±3.79 177.85±1.33* 179.43±4.35* 172.32±2.43* 188.91±2.23* 
Day 15 97.38±3.11 169.12±2.25* 94.13±4.27* 93.00±3.81* 93.50±4.538* 86.63±4.12* 
%  
-0.02%* 13.33%* 52.37%* 53.62%* 53.93%* 58.80%* 
Asterisks (*) indicates significant (p<0.05) difference compared to normal control rats. % Per-
centage decrease in glucose level on day 15. 
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Table 2: Effect of methanol leaf extract of Moringa oleifera on body weight of  
               rats before induction of diabetes and day 15 post administration of  
               extract  
 
Norm – Normal, Diab – Diabetic, Ext- Moringa oleifera extract, Rosigl – Rosiglitazone. 
Asterisks (*) indicates significant (p<0.05) difference compared to normal control rats 
Group Day 0 (gm) Day 15 (gm)   Weight gain (gm)   
Norm Control 201.24±1.23 209.75±2.17   8.51 
Diab control 175.00±2.13 137.88±5.42   -37.12* 
Ext 200mg/kg 150.53±1.54 158.50±1.25   7.97 
Ext 400mg/kg 151.01±2.35 159.50±1.15   8.49 
Ext 800mg/kg 150.67±2.15 161.62±2.34   10.95* 
Rosigl 2mg/kg 151.92±2.34 165.86±2.14   13.94* 
Table 3: Effect of methanol extract of Moringa oleifera leaf on lipid profile of 
               diabetic rats  
Norm – Normal, Diab – Diabetic, Ext- Moringa oleifera extract, Rosigl – Rosiglitazone, Trigly – Triglycerides,  
TC – Total Cholesterol, HDL-C - High density lipoprotein cholesterol, LDL-C - Low density lipoprotein  
cholesterol, VLDL-C - Very low Density lipoprotein cholesterol. Asterisks (*) indicates significant (p<0.05)  
difference compared to normal control rats 
Group TG (mg/dl) TC (mg/dl) HDL-C (mg/dl) LDL-C (mg/dl) VLDL-C (mg/dl) 
Norm Control 87.88±7.10 59.00±5.10 42.50±3.09 35.00±5.46 10.38±1.21 
Diab control 120.14±4.23* 63.29±5.17 35.86±2.96* 56.71±2.14* 12.57±1.04 
Ext 200mg/kg 96.62±4.40 51.50±3.85* 46.13±4.54 28.25±3.30ab* 10.29±0.77 
Ext 400mg/kg 93.13±4.94 52.50±4.36* 54.88±4.70* 26.63±4.89* 10.49±0.88 
Ext 800mg/kg 85.75±2.20 46.75±5.15* 46.75±5.15 23.88±6.25* 9.10±0.42 
Rosigl 2mg/kg 102.13±4.63* 55.63±3.95 40.63±2.89 32.63±2.98 11.86±0.67 
Table 4: Effect of Moringa oleifera leaf extract on serum proteins, liver enzymes   












TP (mg/dl) 5.60±0.24 4.33±0.36 6.11±0.57* 6.00±0.34* 5.67±0.37 5.53±0.36 
Alb(mg/dl) 3.36±0.23 2.85±0.31 4.40±0.32* 4.00±0.36* 3.75±0.35 3.38±0.31 
Glob(mg/dl) 2.21±0.20 1.42±0.30* 1.70±0.43 1.96±0.28 1.89±0.36 2.09±0.29 
ALP (µ/l) 87.63±40.9 98.00±4.94 84.63±5.55 81.88±7.61 85.25±6.06 70.75±9.43* 
ALT (µ/l) 21.88±1.48 36.29±2.91* 28.00±1.93 25.88±2.38 27.63±2.51 23.00±2.17 
AST (µ/l) 53.50±2.34 61.71±4.60* 48.25±2.98 48.50±0.03 47.13±2.00 49.12±1.30 
Urea (mg/dl) 8.88±0.90 14.00±1.20* 8.25±0.98 8.00±0.71 8.50±0.72 8.13±0.83 
Creatinine 
(mg/dl) 
0.24±0.03 0.31±0.04 0.17±0.02* 0.14±0.02* 0.14±0.01* 0.13±0.03* 
Asterisks (*) indicate significant difference compared to normal control rats. Norm – Normal, Diab – Dia-
betic, Ext- Moringa oleifera extract, Rosigl – Rosiglitazone, TP–Total protein, Alb–Albumin, Glob–
Globulin, ALP-Alkaline phosphatase, ALT-Alanine aminotransferase, AST- Aspartate aminotransferase  
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DISCUSSION 
In this study, the leaf extract of Moringa oleif-
era significantly (p<0.05) reduced elevated 
blood glucose levels in the diabetic rats and 
corrected the weight loss and dyslipidaemia 
observed in diabetes. Elevations in glucose 
levels accompanied by chronic weight loss, 
hypercholesterolemia, hypertriglyceridemia, 
high levels of low density lipoprotein (LDL-
C), and low levels of high density lipopro-
tein (HDL-C) are typical clinical findings 
associated with diabetes mellitus (ADA, 
2007; Otamere et al., 2011). Combinations 
of these clinical derangements increases risk 
for development of cardiovascular diseases 
and other complications of diabetes (Craig 
et al., 1998; Barrett-Connor et al., 2004). In 
this study, alloxan was used to induce diabe-
tes. Alloxan is known to rapidly deplete β-
cells of Islets of Langerhans by alkylation of 
DNA and accumulation of cytotoxic free 
radicals which initiates the inflammatory 
response, which is followed by infiltration 
of activated macrophages and lymphocytes. 
A reduction in insulin release occurs with a 
stable hyperglycemic state (Devasagayam et 
al., 2012).  
 
This study showed that the methanol ex-
tract of Moringa oleifera significantly (p<0.05) 
reduced the blood glucose levels of the dia-
betic rats within 18 hours of its administra-
tion, with gradual return to normal levels by 
day 15 observation. The weight gain of 
these rats was consistent with that of the 
non-diabetic rats through the course of the 
experiment, while the diabetic control rats 
showed all the clinical signs typical of diabe-
tes. The extract also significantly (p<0.05) 
lowered the levels of total cholesterol, tri-
glycerides, LDL-C and VLDL-C and in-
creased the levels of HDL-C in a dose de-
pendent pattern. The extract was more ef-
fective in reversing the dyslipidemia associ-
ated with diabetes than rosiglitazone, a 
known thiazolidinedione anti-diabetic agent.  
 
One of the major focuses of management of 
diabetes is lowering of cardiovascular risk 
factors alongside maintaining normal range 
levels of blood glucose. Lipoproteins play an 
essential role in determination of these risk 
factors (Saba and Oridupa, 2012). Very low 
density lipoprotein (VLDL-C) contains the 
largest amount of cholesterol, followed by 
LDL-C (Carmena et al., 2004). The leaf ex-
tract of M. oleifera effectively lowered these 
atherogenic lipoproteins and total cholesterol 
levels, but increased high density lipoprotein 
(HDL-C). HDL-C contains the least amount 
of cholesterol and the ratio of HDL-C to 
LDL-C represent the atherogenic index 
which can be used to determine risk of de-
velopment of cardiovascular diseases, a ma-
jor complication of diabetes (Khera et al., 
2011; Saba and Oridupa, 2012). In this study, 
diabetic rats treated with M. oleifera leaf ex-
tract showed a remarkable lowering of their 
risk factors and better management of the 
diabetes compared to rosiglitazone –treated 
rats. 
 
Other damages done by alloxan importantly 
include liver injury (El-Demerdash et al., 
2005; Ragavan and Krishnakumari, 2006; 
Daryoush et al., 2011). Most drugs including 
alloxan are detoxified in the liver, which 
makes it prone to hepatotoxicity and this 
may be detected by increases in serum levels 
of liver enzymes; alanine aminotransferase 
(ALT), aspartate aminotransferase (AST) and 
alkaline phosphatase (ALP) (Jansen and Mul-
ler, 1999). Liver enzymes of extract-treated 
rats in this study were significantly lower 
than that observed in the diabetic control 
rats which clearly showed that alloxan pro-
duced liver damage, but the extract reversed 
the damage(s) done. Other essential func-
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tions of the liver such as glucose store, gly-
colysis and gluconeogenesis in the body 
were normal in the extract treated rats but 
hyperglycemia was observed in the diabetic 
control rats. This shows the storage ability 
of the liver in these diabetic rats had been 
compromised with the evidence of disrup-
tion in normal glucose storage mechanisms.  
 
The liver is also responsible for synthesis of 
proteins which are vital carriers and main-
tain colloidal pressure in the blood (Saba et 
al., 2010). In the study, it was observed that 
the extract of M. oleifera increased protein 
synthesis, particularly the albumin fraction 
of proteins in a manner comparable to the 
effect of rosiglitazone. Other non-protein 
metabolites such as urea, bilirubin and cre-
atinine also are conjugated and excreted via 
bile from the liver. The extract lowered se-
rum levels of metabolites which further 
rules out the presence of hepatic injury 
(Moseley, 1999; Wiwanitkit, 2001; Waikar 
and Bonventre, 2006), expected from allox-
an toxicity. All these taken together, this 
plant can be said to prevent and attenuate 
the development of nephropathies associat-
ed with diabetic complications.  
 
CONCLUSION 
In conclusion, this study has elaborately 
studied the effect of the methanol extract of 
the leaves of Moringa oleifera on diabetes. It 
was observed that the extract of the leaves 
did not only lower blood glucose levels and 
correct the dyslipidemia associated with dia-
betes, but also protected the liver from inju-
ries caused by alloxan. Thus, normal liver 
functions such as glucose store, protein syn-
thesis, conjugation and excretion of metab-
olites were enhanced. M. oleifera is known to 
possess anti-oxidant activity (Kumar and 
Pari, 2003; Santos et al., 2012) which we be-
lieve must have reversed the hepatotoxicity 
in this study. Further studies are hereby rec-
ommended to determine the mechanism of 
hepato-protection by Moringa oleifera. 
 
REFERENCES 
American Diabetes Association (ADA), 
2007. Standards of medical care in diabetes. 
Diabetes Care, 30: 4-41. 
 
Anwar, F., Ashraf, M., Bhanger, M.I. 
2005. Interprovenance variation in the com-
position of Moringa oleifera oil seeds from Pa-
kistan. Journal of American Oil and Chemical 
Society 82: 45–51.  
 
Anwar, F., Bhanger, M.I. 2003. Analytical 
characterization of Moringa oleifera seed oil 
grown in temperate regions of Pakistan. Jour-
nal of Agriculture and Food Chemistry 51: 6558–
6563  
 
Anwar, F., Latif, S., Ashraf, M., Gilani, 
A.H. 2007. Moringa oleifera: A food plant with 
multiple medicinal uses. Phytotherapy Research 
21: 17-25  
 
Barrett-Connor, E., Giardian, E.G., Gitt, 
A.K., Gudat, U., Steinberg, H.O., 
Tscheope, D. 2004. Women and heart dis-
ease; The role of diabetes and hyperglycemia. 
Archives of Internal Medicine, 164(9): 9344-942. 
 
Bharali, R., Tabassum, J., Azad, M.R.H. 
2003. Chemomodulatory effect of Moringa 
oleifera, Lam, on hepatic carcinogen metabo-
lizing enzymes, anti-oxidant parameters and 
skin papillomagenesis in mice. Asia Pacific 
Journal of Cancer Prevention 4: 131–139  
 
Broin, M., Santaella, C., Cuine, S., Ko-
kou, K., Peltier, G., Joet, T. 2002. Floccu-
lent activity of a recombinant protein from 
Moringa oleifera Lam. seeds. Applied Microbiolo-
gy and Biotechnology 60: 114– 119.  
ANTIDIABETIC AND HYPOLIPIDEMIC EFFECTS OF…...  
38 J. Nat. Sci. Engr. Tech. 2012, 11(2): 32-41 
Carmena, R., Duriez, P., Fruchart, J.C. 
2004. Atherogenic lipoprotein particles in 
atherosclerosis. Circulation 109: 2-7. 
 
Craig, W.Y., Neveux, L.M., Palomaki, 
G.E., Cleveland, M.M., Hadow J.E. 
1998. Lipoprotein (a) as a risk factor for 
ischemic heart disease: Metaanalysis of pro-
spective studies. Clinical Chemistry, 44(11):b 
2301-2306 
 
Dangi, S.Y., Jolly, C.I., Narayana, S. 
2002. Antihypertensive activity of the total 
alkaloids from the leaves of Moringa oleifera. 
Pharmaceutical Biology 40: 144–148  
 
Daryoush, M., Bahram, A.T., Yousef, 
D., Mehrdad, N., 2011. Brassica rapa L. 
extract alleviate early hepatic injury in allox-
an-induced diabetic rats. Journal of Medicinal 
Plants Research 5 (31): 6813 -6821. 
 
Devasagayam, H.K., Ashodi, D., Nate-
san, S, 2012. Evaluation of anti-diabetic 
activity of ethanolic and aqueous extracts of 
stem and leaves of Alangium salvifolium and 
Pavonia zeylanica. Asian Pacifici Journal of Tropi-
cal Biomedicine 1:1-5. 
 
El-Demerdash FM, Yousef MI, El-Naga 
NIA, 2005. Biochemical study on the hypo-
glycemic effects of onion and garlic in allo-
xan-induced diabetic rats. Food and Chemical 
Toxicology 43: 57-63. 
 
Fahey, J.W. 2005. Moringa oleifera: A review 
of the medical evidence for its nutritional, 
therapeutic, and prophylactic properties. 
Part 1. Trees for Life Journal 
 
Faizi, S., Siddiqui, B.S., Saleem, R., 
Aftab, K., Shaheen, F., Gilani, A.H. 
1998. Hypotensive constituents from the 
pods of Moringa oleifera. Planta Medica 64: 225
–228. 
Ghasi, S., Nwobodo, E., Ofili, J.O. 2000. 
Hypocholesterolemic effects of crude extract 
of leaf of Moringa oleifera Lam in high-fat diet 
fed Wistar rats. Journal of Ethnopharmacology 
69: 21– 25 
 
Gopalan, C., Sastri, R.B.V., Balasubra-
manian, S.C. (1989). Nutritive Value of In-
dian Foods. National Institute of Nutrition, 
Indian Council of Medical Research 
 
Jansen, P.L., Muller, M., 1999. Early 
events in sepsis-associated cholestasis. Gas-
troenterology 116: 486-488 
 
Kalogo, Y., Rosillon, F., Hammes, F., 
Verstraete W. 2000. Effect of a water ex-
tract of Moringa oleifera seeds on the hydrolyt-
ic microbial species diversity of a UASB re-
actor treating domestic wastewater. Letters of 
Applied Microbiology 31: 259–264  
 
Khera, A.V., Cuchel, M., de la Llera-
Moya, M., Rodrigues, A., Burke, M.F., 
Jafri, K., French, B.C., Phillips, J.A., 
Mucksavage, M.L., Wilensky, R.L., 
Mohler, E.R., Rothblat, G.H. & Rader, 
D.J. (2011). Cholesterol Efflux Capacity, 
High-Density Lipoprotein Function, and 
Atherosclerosis. New England Journal of Medi-
cine 364: 127-135. 
 
Kumar, A., Pari, L. 2003. Antioxidant ac-
tion of Moringa oleifera Lam. (drumstick) 
against antitubercular drugs induced lipid 
peroxidation in rats. Journal of Medicinal Food 6
(3): 255-259. 
 
Lalas, S., Tsaknis, J. 2002. Extraction and 
identification of natural antioxidants from 
the seeds of Moringa oleifera tree variety of 
Malavi. Journal of American Oil Chemical Society 
79: 677–683.  
A .B. SABA, S. A. RAHMAN, O. A.ORIDUPA 
39 J. Nat. Sci. Engr. Tech. 2012, 11(2): 32-41 
 
Mahajan, S.G., Mali, R.G., Mehta, A.A. 
2007. Protective effect of ethanolic extract 
of seeds of Moringa oleifera Lam. against in-
flammation associated with development of 
arthritis in rats. Journal of Immunotoxicology 4 
(1): 39-47 
 
Makonnen, E., Hunde, A., Damecha, G. 
1997. Hypoglycaemic effect of Moringa steno-
petala aqueous extract in rabbits. Phytotherapy 
Research 11: 147–148. 
 
Morton, J.F. 1991. The horseradish tree, 
Moringa pterygosperma (Moringaceae) - A 
boon to arid lands? Economic Botany 45 (3): 
318-333 
 
Moseley, R.H. 1999. Sepsis and choles-
tasis. Clinical Liver Disease 3,465-475 
 
Murakami, A., Kitazono, Y., Jiwajinda, 
S., Koshimizu, K., Ohigashi, H. 1998. 
Niaziminin, a thiocarbamate from the leaves 
of Moringa oleifera, holds a strict structural 
requirement for inhibition of tumor-
promoter- induced EpsteinBarr virus activa-




Ndong, M., Uehara, M., Katsumata, S., 
Suzuki, K. 2007. Effects of oral administra-
tion of Moringa oleifera Lam on glucose toler-
ance in Goto-Kakizaki and Wistar Rats. 
Journal of Clinical Biochemistry and Nutrition 40 
(3): 229–233. 
 
Nikkon, F., Saud, Z.A., Rehman, M.H., 
Haque, M.E. 2003. In vitro antimicrobial 
activity of the compound isolated from 
chloroform extract of Moringa oleifera Lam. 
Pakistan Journal of Biological Sciences 22: 1888–
1890 
 
Otamere, H.O., Aloamaka, C.P., 
Okokhere, P.O., Adisa, W.A., 2011. Lipid 
profile in diabetes mellitus: What impact has 
age and duration. British Journal of Pharmacolo-
gy Toxicology 2(3): 135-137. 
 
Peixoto, J.R., Silva, G.C., Costa, R.A., de 
Sousa Fontenelle, J.R., Vieira, G.H., Fil-
ho, A.A., dos Fernandes Vieira, R.H. 
2011. In vitro antibacterial effect of aqueous 
and ethanolic Moringa leaf extracts. Asian 
Pacific Journal Tropical Medicine 4 (3): 201–204. 
 
Peter, K.V. 2008. Underutilized and Under-
exploited Horticultural Crops. Volume 4. 
New India Publishing. pp. 112. ISBN 81-
89422-90-1. 
 
Ragavan, B., Krishnakumari, S. 2006. Ef-
fect of T. arjuna stem bark extract on histo-
pathology of liver, kidney and pancreas of 
alloxan-induced diabetic rats. African Journal 
of Biomedical Research 9: 189-197. 
 
Roloff, A., Weisgerber, H., Lang, U., 
Stimm, B. 2009. Moringa oleifera, Weinheim 
978–3 
 
Saba, A.B., Oridupa. O.A. 2012. Lipopro-
teins and cardiovascular diseases. In: Lipo-
proteins – Role in health and diseases, Chap-
ter 8. Pp 197 -222. Available at http://
dx.doi.org/10.5772/48132  
 
Saba, A.B., Oridupa, O.A., Oyagbemi, 
A.A., Alao, E.O. 2010. Safety evaluation of 
ethanolic extract of whole fruit of Lagenaria 
breviflora Robert in Wistar rats. African Journal 
of Biotechnology 9(42): 7128-7133 
 
Santos, A.F.S., Argolo, A.C.C., Paiva, 
P.M.G., Coelho, L.C.B.B. 2012. Anti-
oxidant activity of Moringa oleífera tissue ex-
ANTIDIABETIC AND HYPOLIPIDEMIC EFFECTS OF…...  
40 J. Nat. Sci. Engr. Tech. 2012, 11(2): 32-41 
tracts. Phytotherapy Research 6(9): 1366-1370. 
 
Schneider, E. 2001. Vegetables from Ama-
ranth to Zucchini: The Essential Reference. 
Harper Collins. ISBN 0-688-15260-0. 
 
Sharma, P., Kumari, P., Srivastava, 
M.M., Srivastava, S. 2006. Removal of 
cadmium from aqueous system by shelled 
Moringa oleifera Lam. seed powder. Biore-
source Technology 97: 299–305. 
 
Siddhuraju, P., Becker, K. 2003. Antioxi-
dant properties of various solvent extracts 
of total phenolic constituents from three dif-
ferent agro-climatic origins of drumstick tree 
(Moringa oleifera Lam.). Journal of Agriculture and 
Food Chemistry 15: 2144–2155. 
 
Waikar, S.S., Bonventre, J.V. 2006. Can we 
rely on Blood urea nitrogen as biomarker to 
determine when to initiate dialysis? Clinical 
Journal of American Society of Nephrology 1: 903–
904. 
 
Wiwanitkit, V. 2001. High serum alkaline 
phosphatase levels, a study in 181 Thai adult 
hospitalized patients. British Medical Compendi-
A .B. SABA, S. A. RAHMAN, O. A.ORIDUPA 
41 
(Manuscript 18th March,, 2013; accepted: 17th July, 2013). 
J. Nat. Sci. Engr. Tech. 2012, 11(2): 32-41 
